Aware (NASDAQ:AWRE - Get Free Report)'s stock had its "sell (d-)" rating reiterated by investment analysts at Weiss Ratings in a report released on Friday,Weiss Ratings reports.
Aware Price Performance
NASDAQ:AWRE traded up $0.04 during trading hours on Friday, reaching $2.49. The company's stock had a trading volume of 27,049 shares, compared to its average volume of 40,511. Aware has a one year low of $1.35 and a one year high of $2.95. The business's 50-day moving average is $2.47 and its 200-day moving average is $2.06. The company has a market cap of $53.07 million, a price-to-earnings ratio of -8.89 and a beta of 0.89.
Aware (NASDAQ:AWRE - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The software maker reported ($0.08) earnings per share (EPS) for the quarter. Aware had a negative net margin of 35.46% and a negative return on equity of 19.04%. The firm had revenue of $3.90 million for the quarter.
Institutional Investors Weigh In On Aware
A number of hedge funds have recently bought and sold shares of the company. Goldman Sachs Group Inc. boosted its holdings in Aware by 71.6% during the first quarter. Goldman Sachs Group Inc. now owns 34,595 shares of the software maker's stock valued at $55,000 after acquiring an additional 14,436 shares during the period. GMT Capital Corp bought a new stake in Aware during the first quarter valued at about $39,000. Finally, Aristides Capital LLC boosted its holdings in Aware by 55.5% during the second quarter. Aristides Capital LLC now owns 206,009 shares of the software maker's stock valued at $389,000 after acquiring an additional 73,500 shares during the period. 24.39% of the stock is currently owned by institutional investors.
About Aware
(
Get Free Report)
Aware, Inc, an authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, the United Kingdom, and internationally. The company offers biometric software solution, including Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification, as well as AFIX Face, AFIX Verifier, AFIX Identifier, AFIX Comparator, AFIX Engine, and AFIX NIST Transaction Engine.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aware wasn't on the list.
While Aware currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.